SCHEMBL4432409

SCHEMBL4432409

COc1cccc2cc(C(=O)NCCOc3ccc(C(N)=O)c(O)c3)oc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.55
ALDH1A1 P00352 2/20 0.55
HDAC1 Q13547 1/20 0.54
HDAC2 Q92769 1/20 0.54
RXFP1 Q9HBX9 2/20 0.53
ADORA2A P29274 6/20 0.52
ADORA1 P30542 2/20 0.52
ADORA2B P29275 3/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
POLB P06746 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
HPGD P15428 1/20 0.49
TSHR P16473 1/20 0.49
DRD2 P14416 1/20 0.48
DRD3 P35462 1/20 0.48
MEN1 O00255 1/20 0.48
MAPT P10636 1/20 0.47
HTT P42858 1/20 0.47
LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL443561 0.82 HDAC1 (0.62) KMT2AALDH1A1HDAC1HDAC2RXFP1
SCHEMBL4248226 0.79 HDAC1 (0.59) KMT2AALDH1A1HDAC1HDAC2RXFP1
SCHEMBL4438351 0.79 HPGD (0.48) KMT2AALDH1A1POLBSMN1; SMN2HPGD
SCHEMBL4438509 0.79 HPGD (0.53) KMT2AALDH1A1HDAC1HDAC2POLB
SCHEMBL4428958 0.78 SMN1; SMN2 (0.52) KMT2AALDH1A1HDAC1HDAC2POLB
SCHEMBL3665639 0.78 HDAC2 (0.52) ALDH1A1HDAC1HDAC2RXFP1ADORA2A
SCHEMBL4426592 0.77 POLB (0.56) KMT2AHDAC1HDAC2NPC1RAB9A
SCHEMBL4033454 0.76 HPGD (0.49) KMT2AALDH1A1HDAC1HDAC2RAB9A
SCHEMBL3664341 0.75 HDAC1 (0.54) ALDH1A1HDAC1HDAC2RXFP1ADORA2A
SCHEMBL5584871 0.74 KMT2A (0.72) KMT2AALDH1A1HDAC1HDAC2RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099442-A1 METHOD OF USING HISTONE DEACETYLASE INHIBITORS AND MONITORING BIOMARKERS IN COMBINATION THERAPY PHARMACYCLICS, INC. (US) 2009-09-16 EP disclosed
WO-2008082856-A1 METHOD OF USING HISTONE DEACETYLASE INHIBITORS AND MONITORING BIOMARKERS IN COMBINATION THERAPY PHARMACYCLICS, INC. (US) 2008-07-10 WO disclosed